Director of Molecular Pathology and Pathology Informatics
Providence St. Joseph Health
Jun 18, 2024
Implementing CGP + HRD testing in-house in a large US Healthcare System
Presented at:
The Power of Comprehensive Genomic Profiling Testing
Speakers
-
Brian Piening, PhD
Associate Member at Earle A. Chiles Research Institute Technical Director Clinical Genomics at Providence St. Joseph Health
Abstract
Homologous recombination repair deficiency (HRD) is associated with response to poly-ADP-ribose polymerase inhibition (PARPi) therapy in advanced ovarian cancer. In combination with CGP, these analyses allow clinicians to maximize clinical information so that patients are matched with approved therapies or enrolled in relevant clinical trials.
In this workshop, a pathologist and laboratory director will discuss the impact of implementing a HRD assay at their institution. They will describe the details of implementing the assay, technical considerations for HRD testing, concordance with other HRD assays, and the added value of offering CGP and HRD testing in-house.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...